1 is a clinical fellow and is an investigator, both at the Liver Diseases Branch of the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health in Bethesda, Maryland.
Despite the availability of an effective hepatitis B vaccine, the global prevalence has not substantially declined, and significant barriers remain to screening and care.